Home β€Ί Stock analysis β€Ί AEMD

Aethlon Medical (AEMD) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)

Updated Oct 16, 2026, 4:00 PM ET

What changed since yesterday

AEMD dips 2.3% to $5.15. Closed at $5.15, -2.28% vs the prior close of $5.27. Day range $5.07–$5.30, opened at $5.30.

Last close$5.15-2.28%
Day range5.07–5.30
Open5.30
Volume37.78K
52-week range1.41–33.50
Avg volume (20d)155.12K

AEMD daily analysis β€” what happened

A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.

Oct 16, 2026 β€” AEMD dips 2.3% to $5.15
Oct 15, 2026 β€” AEMD jumps 4.4% to $5.27
Oct 14, 2026 β€” AEMD slides 9.5% to $5.05, 3 down days in a row
Oct 13, 2026 β€” AEMD slides 4.8% to $5.58
Oct 12, 2026 β€” AEMD slides 3.1% to $5.86
Oct 9, 2026 β€” AEMD rises 0.7% to $6.05
Oct 8, 2026 β€” AEMD dips 1.0% to $6.01, 3 down days in a row
Oct 7, 2026 β€” AEMD dips 0.3% to $6.07
Oct 6, 2026 β€” AEMD slides 6.7% to $6.09
Oct 5, 2026 β€” AEMD rises 1.2% to $6.53
Oct 2, 2026 β€” AEMD dips 2.7% to $6.45

AEMD latest news & SEC filings

Every SEC filing by or about AEMD in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.

Oct 15, 2026 Β· Form 4 β€” Insider trade

Insider trade report (Form 4) β€” a director, officer or 10%+ owner changed their holdings

Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.

Source: SEC EDGAR filing 0001683168-26-007901

Oct 15, 2026 Β· Form 4 β€” Insider trade

Insider trade report (Form 4) β€” a director, officer or 10%+ owner changed their holdings

Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.

Source: SEC EDGAR filing 0001683168-26-007881

Oct 15, 2026 Β· Form 4/A β€” Insider trade (amended)

Amended insider trade report (Form 4/A)

Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.

Source: SEC EDGAR filing 0001683168-26-007880

Oct 15, 2026 Β· Form 4 β€” Insider trade

Insider trade report (Form 4) β€” a director, officer or 10%+ owner changed their holdings

Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.

Source: SEC EDGAR filing 0001683168-26-007879

Oct 15, 2026 Β· Form 4 β€” Insider trade

Insider trade report (Form 4) β€” a director, officer or 10%+ owner changed their holdings

Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.

Source: SEC EDGAR filing 0001683168-26-007878

Oct 13, 2026 Β· Form 4 β€” Insider trade

Insider trade report (Form 4) β€” a director, officer or 10%+ owner changed their holdings

Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.

Source: SEC EDGAR filing 0001683168-26-007822

Oct 13, 2026 Β· Form SCHEDULE 13G β€” Passive stake (13G)

Passive stake (13G) β€” an investor reported owning more than 5%

Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.

Source: SEC EDGAR filing 0001595888-26-000121

Oct 9, 2026 Β· Form 8-K β€” Major event / current report

Current report β€” a filing companies must make within 4 business days of a major event

Source: SEC EDGAR filing 0001683168-26-007749

Oct 5, 2026 Β· Form 8-K/A β€” Current report (amended)

Amended current report

Source: SEC EDGAR filing 0001683168-26-007613

Oct 1, 2026 Β· Form 8-K β€” Major event / current report

Current report β€” a filing companies must make within 4 business days of a major event

Source: SEC EDGAR filing 0001683168-26-007542

Sep 17, 2026 Β· Form 425 β€” 425 filing

425 filing

Source: SEC EDGAR filing 0001683168-26-007208

Sep 17, 2026 Β· Form 8-K β€” Major event / current report

Current report β€” a filing companies must make within 4 business days of a major event

Source: SEC EDGAR filing 0001683168-26-007206

Sep 15, 2026 Β· Form 8-K β€” Major event / current report

Current report β€” a filing companies must make within 4 business days of a major event

Source: SEC EDGAR filing 0001683168-26-007126

Sep 4, 2026 Β· Form DEFA14A β€” Additional proxy materials

Additional proxy materials

Source: SEC EDGAR filing 0001683168-26-006969

Sep 1, 2026 Β· Form DEF 14A β€” Proxy statement

Proxy statement β€” agenda for the shareholder meeting (board elections, executive pay, votes)

Source: SEC EDGAR filing 0001683168-26-006844

Things to know before you trade AEMD

AEMD market data (last 20 sessions)

DateOpenHighLowCloseVolume
Oct 16, 20265.305.305.075.1537.78K
Oct 15, 20265.005.465.005.2764.50K
Oct 14, 20265.555.654.985.05144.30K
Oct 13, 20265.805.845.585.5843.80K
Oct 12, 20266.016.055.825.8644.90K
Oct 9, 20266.126.186.036.0515.00K
Oct 8, 20266.026.096.006.0124.70K
Oct 7, 20266.026.186.006.0728.30K
Oct 6, 20266.356.516.096.0975.50K
Oct 5, 20266.506.586.346.5395.50K
Oct 2, 20266.546.696.386.4540.80K
Oct 1, 20266.516.666.266.6364.00K
Sep 30, 20266.406.666.276.52118.50K
Sep 29, 20266.256.426.126.3859.20K
Sep 28, 20266.156.465.956.38141.10K
Sep 25, 20266.646.676.166.28133.50K
Sep 24, 20266.696.816.366.77150.00K
Sep 23, 20266.566.946.316.81300.00K
Sep 22, 20266.207.216.206.57764.60K
Sep 21, 20266.896.936.036.32756.40K

About Aethlon Medical

Aethlon Medical (AEMD) is listed on the Nasdaq and classified by the SEC under β€œSurgical & Medical Instruments & Apparatus”. Its business address is in SAN DIEGO, CA. State of incorporation: NV. Fiscal year ends March 31. SEC CIK 882291.

AEMD board of directors & executives

From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).

Directors

NameRoleLatest filing
Edward G BroennimanDirectorJul 1, 2026
Nicolas GikakisDirectorJul 1, 2026
Angela RossettiDirectorApr 21, 2026
Chetan ShahDirectorJul 1, 2026

Executive officers

NameTitleLatest filing
No Form 3/4/5 filings by this group in the last 12 months.

Recent insider buys & sales

DateInsiderTypeSharesPrice
No open-market insider buys or sales reported in the last 12 months.

AEMD financials (annual, from XBRL filings)

Fiscal year endRevenueNet incomeDiluted EPSOperating cash flow
Mar 31, 2026β€”$-7.15M-10.61$-7.00M
Mar 31, 2025β€”$-13.39M-85.77$-7.65M
Mar 31, 2024$0$-12.21M-38.87$-10.13M
Mar 31, 2023$574.25K$-12.03M-5.86$-10.51M
Mar 31, 2022$294.17K$-10.42M-0.71$-9.77M

Latest balance sheet: total assets $6.24M, total liabilities $1.45M, cash $4.93M (as of Jun 30, 2026).

AEMD earnings / results-day log

DateFilingClose that day
Aug 13, 20268-K Item 2.02 (results)$2.93
Jun 10, 20268-K Item 2.02 (results)$10.10
Feb 12, 20268-K Item 2.02 (results)$9.90
Nov 12, 20258-K Item 2.02 (results)$21.00
Aug 13, 20258-K Item 2.02 (results)$61.50
Jun 27, 20258-K Item 2.02 (results)$62.50
Feb 12, 20258-K Item 2.02 (results)$268.00
Nov 13, 20248-K Item 2.02 (results)$164.00
Aug 14, 20248-K Item 2.02 (results)β€”
Jun 27, 20248-K Item 2.02 (results)β€”
Feb 14, 20248-K Item 2.02 (results)β€”
Nov 14, 20238-K Item 2.02 (results)β€”

Related stocks Β· Surgical & Medical Instruments & Apparatus

Boston Scientific (BSX)Stryker (SYK)3M (MMM)Dexcom (DXCM)Medline (MDLN)Becton Dickinson (BDX)MiniMed (MMED)Resmed (RMD)Insulet (PODD)West Pharmaceutical Services (WST)

Popular today

Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)

More on AEMD

Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.